WorldPolitics

Guinea-Bissau denies it has approved controversial vaccine trial in newborns

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 14/10/2026, 12:39:24 UTC.

Briefings

Health Minister of Guinea-Bissau explicitly denied authorization for a Danish-led hepatitis B vaccine trial in newborns, citing US government backing and Robert F Kennedy Jr. as key supporters. The trial would track nonspecific health outcomes like mortality and neurodevelopment rather than vaccine safety or effectiveness. The evidence indicates the trial was not approved by the local government, though the specific funding mechanism and timeline remain unclear.

Key points

• Guinea-Bissau's Health Minister explicitly denied authorization for a Danish-led hepatitis B vaccine trial in newborns, stating the government 'did not authorize' the study.
• The trial was supported by the US Department of Health and Human Services and Robert F Kennedy Jr, who is an anti-vaccine activist.

Context and limitations

The evidence covers the minister's denial and the trial's nature but lacks details on the specific funding timeline, exact dates of the trial, or the specific outcomes observed during the study.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 14/10/2026, 13:24:11 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeia5h2py27gt2xsbib5jvav5xhxdbem4uk45glnhzqbxltwunm5ply